Andrew H.

Andrew H. has a diverse work experience in various roles and industries. Andrew started their career at Northern Kentucky University as a Laboratory Manager and Research Scientist from 2011 to 2016. Andrew then joined Medpace, where they worked as a Senior Proposal Writer from 2016 to 2019 and later became a Manager of Proposal Development from 2019 to 2020. Currently, they hold the position of Manager, Business Operations at Translational Drug Development (TD2) since January 2022 and has recently been promoted to the role of Director of Business Operations in February 2023.

From 2010 to 2014, Andrew H. attended Northern Kentucky University, where they obtained a Bachelor of Science (B.S.) degree in Biological Sciences with a focus on Cellular/Molecular Genetics.